| Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3 ML Shiffman, F Suter, BR Bacon, D Nelson, H Harley, R Solá, SD Shafran, ... New England Journal of Medicine 357 (2), 124-134, 2007 | 773 | 2007 |
| Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial F Saliba, C Camus, F Durand, P Mathurin, A Letierce, B Delafosse, ... Annals of internal medicine 159 (8), 522-531, 2013 | 304 | 2013 |
| “A la carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding C Bureau, JM Péron, L Alric, J Morales, J Sanchez, K Barange, JL Payen, ... Hepatology 36 (6), 1361-1366, 2002 | 292 | 2002 |
| Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation N Kamar, O Marion, L Rostaing, O Cointault, D Ribes, L Lavayssière, ... American Journal of Transplantation 16 (5), 1474-1479, 2016 | 245 | 2016 |
| Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices K Barange, JM Péron, K Imani, P Otal, JL Payen, H Rousseau, JP Pascal, ... Hepatology 30 (5), 1139-1143, 1999 | 224 | 1999 |
| Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals M Mavigner, M Cazabat, M Dubois, FE L’faqihi, M Requena, C Pasquier, ... The Journal of clinical investigation 122 (1), 62-69, 2012 | 204 | 2012 |
| Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases JP Zarski, P Marcellin, V Leroy, C Trepo, D Samuel, N Ganne-Carrie, ... Journal of hepatology 45 (3), 355-360, 2006 | 185 | 2006 |
| Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study C Payan, F Roudot‐Thoraval, P Marcellin, N Bled, G Duverlie, ... Journal of viral hepatitis 12 (4), 405-413, 2005 | 184 | 2005 |
| Histopathologic analysis of transjugular intrahepatic portosystemic shunts H Ducoin, J El-Khoury, H Rousseau, K Barange, J Peron, M Pierragi, ... Hepatology 25 (5), 1064-1069, 1997 | 115 | 1997 |
| The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010 MA Loko, D Salmon, P Carrieri, M Winnock, M Mora, L Merchadou, ... BMC infectious diseases 10, 1-11, 2010 | 95 | 2010 |
| Acute renal failure following liver transplantation with induction therapy. J Guitard, O Cointault, N Kamar, F Muscari, L Lavayssiere, B Suc, D Ribes, ... Clinical nephrology 65 (2), 2006 | 89 | 2006 |
| Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-α plus ribavirin F Legrand-Abravanel, K Sandres-Saune, K Barange, L Alric, J Moreau, ... The Journal of infectious diseases 189 (8), 1397-1400, 2004 | 86 | 2004 |
| Incidence of venous thromboembolism in patients with newly diagnosed pancreatic cancer and factors associated with outcomes C Frere, B Bournet, S Gourgou, J Fraisse, C Canivet, JM Connors, ... Gastroenterology 158 (5), 1346-1358. e4, 2020 | 79 | 2020 |
| Impact of chromoscopy on adenoma detection in patients with Lynch syndrome: a prospective, multicenter, blinded, tandem colonoscopy study G Rahmi, T Lecomte, D Malka, T Maniere, M Le Rhun, R Guimbaud, ... Official journal of the American College of Gastroenterology| ACG 110 (2 …, 2015 | 70 | 2015 |
| Complete endoscopic sphincterotomy with vs. without large-balloon dilation for the removal of large bile duct stones: randomized multicenter study D Karsenti, E Coron, G Vanbiervliet, J Privat, E Kull, P Bichard, B Perrot, ... Endoscopy 49 (10), 968-976, 2017 | 61 | 2017 |
| Peginterferon alpha‐2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon … A Abergel, C Hezode, V Leroy, K Barange, JP Bronowicki, A Tran, L Alric, ... Journal of viral hepatitis 13 (12), 811-820, 2006 | 59 | 2006 |
| RANDOMIZED CONTROLLED MULTICENTER TRIAL EVALUATING THE EFFICACY AND SAFETY OF ALBUMIN DIALYSIS WITH MARS (R) IN PATIENTS WITH FULMINANT AND SUBFULMINANT HEPATIC FAILURE F Saliba, C Camus, F Durand, P Mathurin, B Delafosse, K Barange, ... Hepatology 48 (4), 377A-377A, 2008 | 49 | 2008 |
| Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH D Salmon, F Bani-Sadr, MA Loko, H Stitou, A Gervais, J Durant, ... Journal of hepatology 56 (4), 862-868, 2012 | 48 | 2012 |
| CCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals C Loiseau, M Requena, M Mavigner, M Cazabat, N Carrere, B Suc, ... Mucosal immunology 9 (5), 1137-1150, 2016 | 46 | 2016 |
| Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy H Bagheri, A Fouladi, K Barange, M Lapeyre‐Mestre, JL Payen, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 24 (11 …, 2004 | 44 | 2004 |
